Muhammad Memon, MD
Vascular & Interventional Radiology · Galveston, TXNPI 1144547134
Payments from drug & device makers
Across 39 payments — averaging $115.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Penumbra, Inc.$2K
- Microvention, Inc.$2K
- Johnson & Johnson$431
- Novartis$141
- AbbVie$130
- Medtronic$95
- plus $134 from 4 others
What the payments were for
- Travel & lodging$2,64259%
- Food & beverage$1,85141%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Penumbra, Inc. | 9 | $1,918 |
| Microvention, Inc. | 10 | $1,644 |
| Johnson & Johnson(2 entities) | 6 | $431 |
| Novartis | 2 | $141 |
| AbbVie | 7 | $130 |
| Medtronic | 1 | $95 |
| Stryker | 1 | $79 |
| SK Life Science, Inc. | 1 | $27 |
| Genentech USA, Inc. | 1 | $15 |
| Lantheus Medical Imaging, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Penumbra System$1,805
- WEB Aneurysm Embolization System$1,260
- LVIS$750
- HydroSoft 3D$533
- Scepter C$533
- V-GRIP DETACHMENT CONTROLLER$304
- Embotrap$128
- EMBOGUARD$124
- CEREPAK UNIFORM$117
- GILENYA$115
How this compares
$4,493 in reported general payments places this provider in the 55th percentile of 299 vascular & interventional radiology providers in Texas.
See all vascular & interventional radiology providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Repatha SureclickEvolocumab | 11 | $5,777 |
| Atorvastatin Calcium | 87 | $614 |
| ClopidogrelClopidogrel Bisulfate | 35 | $550 |
Paid to pharmacies, not to this prescriber.
Other vascular & interventional radiology in Galveston
- Arsalan SaleemGalveston$31K
- Armeen MahvashHouston$2.6M
- Rony AvritscherHouston$1.3M
- Orlando DiazHouston$699K
- Sanjeeva KalvaDallas$581K
- Rahul ShethHouston$511K
- Miguel MonteroHouston$482K
- Marshall HicksHouston$403K
- Ahmed Abdel AalHouston$372K
- Joshua KubanHouston$349K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.